Cytomx Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomx Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $52k | 16k | 3.19 |
| 2025-03-31 | $67k | 105k | 0.64 |
| 2024-12-31 | $836k | 812k | 1.03 |
| 2024-09-30 | $332 | 281 | 1.18 |
| 2024-06-30 | $342 | 281 | 1.22 |
| 2024-03-31 | $613 | 281 | 2.18 |
| 2023-12-31 | $435 | 281 | 1.55 |
| 2023-09-30 | $2.2k | 1.7k | 1.29 |
| 2023-06-30 | $3.0k | 1.7k | 1.72 |
| 2023-03-31 | $3.0k | 1.7k | 1.73 |
| 2022-12-31 | $3.0k | 1.7k | 1.73 |
| 2022-06-30 | $5.0k | 3.0k | 1.68 |
| 2022-03-31 | $814k | 305k | 2.67 |
| 2021-12-31 | $1.3M | 307k | 4.27 |
| 2021-03-31 | $559k | 72k | 7.74 |
| 2020-12-31 | $528k | 81k | 6.55 |
| 2020-09-30 | $620k | 92k | 6.71 |
| 2020-06-30 | $829k | 100k | 8.33 |
| 2020-03-31 | $1.3M | 176k | 7.65 |
| 2019-12-31 | $3.1M | 369k | 8.33 |
| 2019-09-30 | $991k | 134k | 7.38 |
| 2019-06-30 | $1.3M | 127k | 10.59 |
| 2019-03-31 | $1.4M | 135k | 10.75 |
| 2018-12-31 | $2.2M | 143k | 15.13 |
| 2018-09-30 | $2.8M | 151k | 18.53 |
| 2018-06-30 | $3.2M | 140k | 22.86 |
| 2018-03-31 | $5.7M | 201k | 28.45 |
| 2017-12-31 | $5.1M | 244k | 21.11 |
| 2017-06-30 | $3.8M | 243k | 15.50 |
| 2017-03-31 | $3.2M | 186k | 17.27 |
| 2016-12-31 | $313k | 29k | 10.98 |